Kestra Advisory Services’s ENDRA Life Sciences NDRA Stock Holding History

Kestra Advisory Services’s Portfolio NDRA Stock Details NDRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13	Closed	-$2.19K	–	2678
2024 Q2	$2.19K	Buy	+13	New	+$5.6K	﹤0.01%	2611

Other funds holding NDRA

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kestra Advisory Services's NDRA Position: Q3 2024 in Review

Kestra Advisory Services sold out of ENDRA Life Sciences (NDRA) in Q3 2024, closing a stake of 13 shares — an estimated $2.19K sold.

Kestra Advisory Services first reported a position in NDRA in Q2 2024 and held it in 1 quarter. The position peaked at $2.19K in Q2 2024. 9 funds tracked by Wall St. Rank hold NDRA as of Q3 2024.

Kestra Advisory Services reported no remaining ENDRA Life Sciences position as of Q3 2024 after selling out during the quarter.
Kestra Advisory Services sold 13 ENDRA Life Sciences shares in Q3 2024, an estimated $2.19K.
Kestra Advisory Services first reported a position in ENDRA Life Sciences in Q2 2024 and held it in 1 quarter.
Kestra Advisory Services's ENDRA Life Sciences position peaked at $2.19K in Q2 2024.
9 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q3 2024.

Based on Kestra Advisory Services's 13F filing for Q3 2024, filed 13 Nov 2024.